Xeris Biopharma Holdings, Inc. Quarterly Current Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Xeris Biopharma Holdings, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2024.
Xeris Biopharma Holdings, Inc. Current Ratio for the quarter ending September 30, 2024 was 198 %, a 4.39% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	198	-9.08	-4.39%	Sep 30, 2024
Q2 2024	199	-17.7	-8.19%	Jun 30, 2024
Q1 2024	192	-37.9	-16.5%	Mar 31, 2024
Q4 2023	185	-61.8	-25%	Dec 31, 2023
Q3 2023	207	-19.2	-8.48%	Sep 30, 2023
Q2 2023	217	-28.2	-11.5%	Jun 30, 2023
Q1 2023	230			Mar 31, 2023
Q4 2022	247			Dec 31, 2022
Q3 2022	226			Sep 30, 2022
Q2 2022	245			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.